Skip header and navigation

Refine By

22 records – page 1 of 3.

Addressing the emergence of pediatric vaccination concerns: recommendations from a Canadian policy analysis.

https://arctichealth.org/en/permalink/ahliterature169730
Source
Can J Public Health. 2006 Mar-Apr;97(2):139-41
Publication Type
Article
Author
Kumanan Wilson
Meredith Barakat
Edward Mills
Paul Ritvo
Heather Boon
Sunita Vohra
Alejandro R Jadad
Allison McGeer
Author Affiliation
Department of Medicine, University of Toronto, Toronto, ON. Kumanan.Wilson@uhn.on.ca
Source
Can J Public Health. 2006 Mar-Apr;97(2):139-41
Language
English
Publication Type
Article
Keywords
Adverse Drug Reaction Reporting Systems
Attitude to Health
Canada
Child
Compensation and Redress
Health Policy
Humans
Immunization Programs
Liability, Legal - economics
Organizational Objectives
Pediatrics
Public Health Administration
Risk assessment
Trust
Vaccines - administration & dosage - adverse effects
Abstract
Ever since the advent of pediatric vaccination, individuals have expressed concerns about both its risks and benefits. These concerns have once again resurfaced among some segments of the population and could potentially undermine national vaccination programs. The views of the public, however, must be considered and respected in the formulation of vaccination policy. We have conducted an analysis of the pediatric vaccination "debate" in the Canadian context. We believe that there is common ground between those who support pediatric vaccination and those who are concerned about these programs. Based on our findings, we believe that the goal of public health authorities should be to maintain trust in vaccines by continuing to meet certain reciprocal responsibilities. To do so, we recommend the following: 1) increased investment in adverse event reporting systems; 2) request for proposals for consideration of a no-fault compensation program; 3) developing pre-emptive strategies to deal with potential vaccine risks; 4) further examination of mechanisms to improve communication between physicians and parents concerned about vaccination. All of these approaches would require additional investment in pediatric vaccination. However, such an investment is easy to justify given the benefits offered by pediatric vaccination and the ramifications of failing to maintain confidence in vaccination programs or missing a vaccine-related adverse event.
Notes
Comment In: Can J Public Health. 2006 Mar-Apr;97(2):86-916619991
PubMed ID
16620003 View in PubMed
Less detail

Compensation Claims for Sub-substandard Care of Patients with Gastroentero-pancreatic Neuroendocrine Tumors: A Nationwide Descriptive Study of Cases Between 2005-2016 in Norway.

https://arctichealth.org/en/permalink/ahliterature286497
Source
Anticancer Res. 2017 10;37(10):5667-5671
Publication Type
Article
Date
10-2017
Author
Kari F Desserud
Ida Bukholm
Jon Arne Søreide
Source
Anticancer Res. 2017 10;37(10):5667-5671
Date
10-2017
Language
English
Publication Type
Article
Keywords
Administrative Claims, Healthcare
Aged
Carcinoma, Neuroendocrine - economics - pathology - therapy
Compensation and Redress - legislation & jurisprudence
Databases, Factual
Delayed Diagnosis - economics
Diagnostic Errors - economics
Female
Gastrointestinal Neoplasms - economics - pathology - therapy
Humans
Liability, Legal - economics
Male
Medical Errors - economics - legislation & jurisprudence
Medical Oncology - economics - legislation & jurisprudence
Medication Errors
Middle Aged
Neoplasm Staging
Norway
Pancreatic Neoplasms - economics - pathology - therapy
Time Factors
Abstract
Management of patients with neuroendocrine tumors of the gastrointestinal tract or pancreas (GEP-NENs) poses diagnostic and therapeutic challenges. This study described the medico-legal claims reported to a national governmental system that oversees compensation to patients with GEP-NENs Materials and Methods: An electronic search of the Norwegian System of Compensation to Patients database was performed to identify claims evaluated between 2005-2016. The clinical information and the medico-legal evaluation were reviewed.
We identified seven patients, five women and two men, with a median age of 57 (range=47-73) years. Delayed diagnosis (median diagnostic delay of 18 (range=6-48) months) was the main cause for claims in six out of the seven patients). Four patients received financial compensation based on the claim judgement.
This review of claims that were evaluated by the Norwegian System of Compensation to Patients showed that a timely diagnosis of GEP-NENs remains a clinical challenge.
PubMed ID
28982884 View in PubMed
Less detail

Court approves final Red Cross bankruptcy plan to compensate blood victims.

https://arctichealth.org/en/permalink/ahliterature191636
Source
Can HIV AIDS Policy Law Rev. 2000;5(4):8
Publication Type
Article
Date
2000
Author
R. Elliott
Source
Can HIV AIDS Policy Law Rev. 2000;5(4):8
Date
2000
Language
English
French
Publication Type
Article
Keywords
Bankruptcy - legislation & jurisprudence
Blood Transfusion - adverse effects
Canada
Disease Transmission, Infectious - legislation & jurisprudence
Humans
Liability, Legal - economics
Red Cross - economics
Abstract
Following two years of negotiations, the insolvent Canadian Red Cross Society received court approval on 14 September 2000 of its plan to compensate victims of Canada's tainted blood tragedy (and pay other creditors).
PubMed ID
11833179 View in PubMed
Less detail

Criminal law and HIV transmission/exposure: another Swedish case.

https://arctichealth.org/en/permalink/ahliterature7281
Source
Can HIV AIDS Policy Law Rev. 2003 Apr;8(1):77
Publication Type
Article
Date
Apr-2003
Author
Richard Elliott
Author Affiliation
Canadian HIV/AIDS Legal Network, Canada. relliott@aidslaw.ca
Source
Can HIV AIDS Policy Law Rev. 2003 Apr;8(1):77
Date
Apr-2003
Language
English
Publication Type
Article
Keywords
Female
HIV Infections - transmission
Humans
Liability, Legal - economics
Sweden
PubMed ID
12924338 View in PubMed
Less detail

Criminal transmission. HIV-infected man gets prison for unprotected sex.

https://arctichealth.org/en/permalink/ahliterature7251
Source
AIDS Policy Law. 2003 Aug 15;18(15):5
Publication Type
Article
Date
Aug-15-2003
Source
AIDS Policy Law. 2003 Aug 15;18(15):5
Date
Aug-15-2003
Language
English
Publication Type
Article
Keywords
Adult
Crime
HIV Infections - transmission
Humans
Liability, Legal - economics
Male
Sexual Partners
Sweden
PubMed ID
14974385 View in PubMed
Less detail

The Danish patient insurance scheme. A comparison with the Swedish system.

https://arctichealth.org/en/permalink/ahliterature214479
Source
J Leg Med. 1995 Sep;16(3):407-15
Publication Type
Article
Date
Sep-1995

Financial compensation for radiotherapy-related adverse events in a judicial system where proof of medical negligence is not required.

https://arctichealth.org/en/permalink/ahliterature193579
Source
Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):209-12
Publication Type
Article
Date
Sep-1-2001
Author
P. Nyandoto
T. Muhonen
T. Hakala
M P Dombrowski
H. Joensuu
Author Affiliation
Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. paul.nyandoto@hus.fi
Source
Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):209-12
Date
Sep-1-2001
Language
English
Publication Type
Article
Keywords
Adult
Aged
Child
Female
Finland
Humans
Liability, Legal - economics
Male
Malpractice - economics - legislation & jurisprudence
Middle Aged
Radiation Injuries - complications - economics
Radiotherapy - adverse effects - utilization
Abstract
To examine the frequency of adverse events related to radiation therapy that lead to financial compensation in a judicial system that is not based on litigation in court but on statutory insurance where proof of medical negligence is not required for obtaining compensation.
In Finland, an injured patient does not sue through the courts, but submits an insurance claim to the Patient Insurance Association. Proof of medical negligence is not required for obtaining compensation. We reviewed all filed claims associated with radiotherapy presented to the Patient Insurance Association from May 1987 to January 1999. During this time period, 1,732,000 patient visits to radiation therapy units were made, and the estimated number of radiotherapy treatments was 86,600. The data collected included descriptions of the adverse events, examination of the radiation therapy procedures followed, assessment of the causal relation of the event to radiotherapy by the therapists involved and by independent reviewers, and the sums used for compensation.
Only 102 patients (about 0.1%) had filed a claim for financial compensation, and in 18 (0.02%) cases the claim led to compensation. The mean national annual expenditure used for compensation was $35,200, and the sums paid in single cases ranged from $310 to $287,430 (median, $1,970). The expenditure used for compensating adverse radiation events was about $4 per treated patient, which is about 0.3% of all radiation therapy costs.
The frequency of radiation therapy injuries that are financially compensated can remain low in an insurance-based judicial system where no litigation or attorneys are involved.
Notes
Comment In: Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1425-6; author reply 1426-711955760
PubMed ID
11516870 View in PubMed
Less detail

Finland: ten-year sentence for HIV transmission and exposure.

https://arctichealth.org/en/permalink/ahliterature151974
Source
HIV AIDS Policy Law Rev. 2008 Dec;13(2-3):46-7
Publication Type
Article
Date
Dec-2008

22 records – page 1 of 3.